These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 11992752)

  • 1. Efficacy of methylphenidate treatment in childhood myotonic dystrophy type 1 and comorbid attention deficit hyperactivity disorder: A case report using eye tracking assessment.
    Sweere DJJ; Hendriksen JGM; Jeroen Vermeulen R; Klinkenberg S
    Brain Dev; 2024 Feb; 46(2):118-121. PubMed ID: 38007339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ESCAP endorses the inclusion of methylphenidate in the WHO model lists of essential medicines and in the Union list of critical medicines.
    Cortese S; Coghill D; Fegert JM; Mattingly GW; Rohde LA; Wong ICK; Faraone SV
    Eur Child Adolesc Psychiatry; 2024 May; 33(5):1605-1608. PubMed ID: 38662057
    [No Abstract]   [Full Text] [Related]  

  • 3. Methylphenidate improves cognitive function and health-related quality of life in survivors of childhood brain tumours.
    Verity SJ; Halliday G; Hill RM; Ryles J; Bailey S
    Neuropsychol Rehabil; 2024 Jan; 34(1):133-153. PubMed ID: 36580420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approaches to Minimise the Neurodevelopmental Impact of Choroid Plexus Carcinoma and Its Treatment.
    Adamski J; Langford V; Finlay JL
    Life (Basel); 2023 Sep; 13(9):. PubMed ID: 37763259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Clinical Trials in Traumatic Brain Injury.
    Ahmed Z
    Brain Sci; 2022 Apr; 12(5):. PubMed ID: 35624914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the Dopaminergic System in the Striatum and Its Association With Functional Recovery or Rehabilitation After Brain Injury.
    Verduzco-Mendoza A; Carrillo-Mora P; Avila-Luna A; Gálvez-Rosas A; Olmos-Hernández A; Mota-Rojas D; Bueno-Nava A
    Front Neurosci; 2021; 15():693404. PubMed ID: 34248494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of methylphenidate for the treatment of mental sequelae after traumatic brain injury.
    Zhang WT; Wang YF
    Medicine (Baltimore); 2017 Jun; 96(25):e6960. PubMed ID: 28640076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylphenidate on Cognitive Improvement in Patients with Traumatic Brain Injury: A Meta-Analysis.
    Huang CH; Huang CC; Sun CK; Lin GH; Hou WH
    Curr Neuropharmacol; 2016; 14(3):272-81. PubMed ID: 26951094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognitive outcome in survivors of childhood acute lymphoblastic leukemia: experience at a tertiary care hospital in Korea.
    Kim SJ; Park MH; Lee JW; Chung NG; Cho B; Lee IG; Chung SY
    J Korean Med Sci; 2015 Apr; 30(4):463-9. PubMed ID: 25829815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of amino acids differs in the brains of Djungarian hamster (P. sungorus) and Roborovskii hamster (P. roborovskii).
    Ikeda H; Kawase T; Nagasawa M; Chowdhury VS; Yasuo S; Furuse M
    Springerplus; 2014; 3():277. PubMed ID: 24936396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term efficacy of methylphenidate in enhancing attention regulation, social skills, and academic abilities of childhood cancer survivors.
    Conklin HM; Reddick WE; Ashford J; Ogg S; Howard SC; Morris EB; Brown R; Bonner M; Christensen R; Wu S; Xiong X; Khan RB
    J Clin Oncol; 2010 Oct; 28(29):4465-72. PubMed ID: 20837955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rational approach to the child with mental retardation for the paediatrician.
    Lemay JF; Herbert AR; Dewey DM; Innes AM
    Paediatr Child Health; 2003 Jul; 8(6):345-56. PubMed ID: 20052328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Side effects of methylphenidate in childhood cancer survivors: a randomized placebo-controlled trial.
    Conklin HM; Lawford J; Jasper BW; Morris EB; Howard SC; Ogg SW; Wu S; Xiong X; Khan RB
    Pediatrics; 2009 Jul; 124(1):226-33. PubMed ID: 19564304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting methylphenidate response in long-term survivors of childhood cancer: a randomized, double-blind, placebo-controlled, crossover trial.
    Conklin HM; Helton S; Ashford J; Mulhern RK; Reddick WE; Brown R; Bonner M; Jasper BW; Wu S; Xiong X; Khan RB
    J Pediatr Psychol; 2010 Mar; 35(2):144-55. PubMed ID: 19465537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth effects of methylphenidate among childhood cancer survivors: a 12-month case-matched open-label study.
    Jasper BW; Conklin HM; Lawford J; Morris EB; Howard SC; Wu S; Xiong X; Shelso J; Khan RB
    Pediatr Blood Cancer; 2009 Jan; 52(1):39-43. PubMed ID: 18855893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylphenidate treatment.
    Weber P; Lütschg J
    Pediatr Neurol; 2002 Apr; 26(4):261-6. PubMed ID: 11992752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attention deficit and hyperactivity disorder in people with epilepsy: diagnosis and implications to the treatment.
    Koneski JA; Casella EB
    Arq Neuropsiquiatr; 2010 Feb; 68(1):107-14. PubMed ID: 20339664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attention-deficit hyperactivity disorder, methylphenidate, and primary encopresis.
    Golubchik P; Weizman A
    Psychosomatics; 2009; 50(2):178. PubMed ID: 19377031
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.